Clincosm LogoSign in Get a demo

Head and Neck Cancer

Showing NaN - NaN of 83
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer Trial in United States (NYU Electronic Patient Visit Assessment (ePVA), Usual Care)

Not yet recruiting
  • Head and Neck Cancer
  • NYU Electronic Patient Visit Assessment (ePVA)
  • Usual Care
  • Kansas City, Kansas
  • +4 more
Sep 1, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

Recruiting
  • Head and Neck Cancer
  • Scottsdale, Arizona
  • +87 more
Dec 12, 2022

Head Neck Cancer Trial in Baltimore, Chapel Hill, Philadelphia (Pembrolizumab, Intensity Modulated Radiation Therapy)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Baltimore, Maryland
  • +2 more
Dec 7, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Head Neck Cancer, Human Papilloma Virus Trial in United States (MEDI0457, CELLECTRA®5P device, Durvalumab)

Completed
Has Results
  • Head and Neck Cancer
  • Human Papilloma Virus
  • San Francisco, California
  • +13 more
Aug 3, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

Urinary Bladder Cancer, Melanoma, Head Neck Cancer Trial in Canada, United States (Autologous genetically modified MAGE-A4?¹º³²T

Active, not recruiting
  • Urinary Bladder Cancer
  • +9 more
  • Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
  • Autologous genetically modified MAGE-A4c1032T cells combined with low dose radiation
  • Miami, Florida
  • +10 more
Aug 9, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Head Neck Cancer Trial in United States (drug, radiation, procedure)

Completed
Has Results
  • Head and Neck Cancer
  • Birmingham, Alabama
  • +194 more
May 23, 2022

Sarcoma, Melanoma, Lung Cancer Trial in United States (PRT1419)

Recruiting
  • Sarcoma
  • +6 more
  • Denver, Colorado
  • +6 more
May 26, 2022

Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Enoblituzumab, Retifanlimab,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Enoblituzumab
  • +2 more
  • Baltimore, Maryland
  • +41 more
May 16, 2022

Head Neck Cancer, Dental Diseases, Osteoradionecrosis Trial in United States

Active, not recruiting
  • Head and Neck Cancer
  • +2 more
    • Farmington, Connecticut
    • +5 more
    Apr 20, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta, Chicago, Philadelphia (Pembrolizumab, Placebo)

    Active, not recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of the Head and Neck
    • Atlanta, Georgia
    • +3 more
    Apr 13, 2022

    Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,

    Active, not recruiting
    • Head and Neck Cancer
    • Birmingham, Alabama
    • +267 more
    Apr 6, 2022

    Head Neck Cancer, Oral Mucositis Trial in Philadelphia (Standard of Care Oral Hygiene, Oral mucosal deterging and dental

    Active, not recruiting
    • Head and Neck Cancer
    • Oral Mucositis
    • Standard of Care Oral Hygiene
    • Oral mucosal deterging and dental prophylaxis
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Apr 1, 2022

    Pulpitis - Irreversible, Caries, Head Neck Cancer Trial in Philadelphia (Root canal treatment and crown)

    Recruiting
    • Pulpitis - Irreversible
    • +2 more
    • Root canal treatment and crown
    • Philadelphia, Pennsylvania
      School of Dental Medicine
    Mar 31, 2022

    Head Neck Cancer, Lymphedema Trial in Philadelphia (Home-based (a hybrid model) CDT, Clinic-based CDT)

    Recruiting
    • Head and Neck Cancer
    • Lymphedema
    • Home-based CDT
    • Clinic-based CDT
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Mar 13, 2022

    Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

    Completed
    Has Results
    • Advanced Solid Tumors
    • +6 more
    • Cabiralizumab
    • Nivolumab
    • Scottsdale, Arizona
    • +38 more
    Jan 5, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Cervical Cancer, Head Neck Cancer, Anal Cancer Trial in United States (RTX-321)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Feb 7, 2022

    Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

    Completed
    • Prostate Cancer
    • +6 more
    • MGA271
    • Los Angeles, California
    • +11 more
    Feb 4, 2022

    HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +4 more
    Feb 1, 2022

    Head Neck Cancer, Lymphedema, Fibrosis Trial in Philadelphia (Low-Level Laser)

    Completed
    Has Results
    • Head and Neck Cancer
    • +2 more
    • Low-Level Laser
    • Philadelphia, Pennsylvania
      University of Pennsylvania Abramson Cancer Center
    Jan 25, 2022